Department of Behavioral Neurogenomics, Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Science, Novosibirsk, Russia.
Genes Brain Behav. 2010 Jul;9(5):519-24. doi: 10.1111/j.1601-183X.2010.00581.x. Epub 2010 Mar 22.
In the present study, the 5-HT(2A) and 5-HT(1A) receptors functional activity and 5-HT(2A) receptor gene expression were examined in the brain of ASC/Icg and congenic AKR.CBAD13Mit76C mouse strains (genetically predisposed to catalepsy) in comparison with the parental catalepsy-resistant AKR/J and catalepsy-prone CBA/Lac mouse strains. The significantly reduced 5-HT(2A) receptor functional activity along with decreased 5-HT(2A) receptor gene expression in the frontal cortex was found in all mice predisposed to catalepsy compared with catalepsy-resistant AKR/J. 5-HT(2A) agonist DOI (0.5 and 1 mg/kg, i.p.) significantly reduced catalepsy in ASC/Icg and CBA/Lac, but not in AKR.CBAD13Mit76C mice. Essential increase in 5-HT(1A) receptor functional activity was shown in catalepsy-prone mouse strains in comparison with catalepsy-resistant AKR/J mice. However, in AKR.CBAD13Mit76C mice it was lower than in ASC/Icg and CBA/Lac mice. The inter-relation between 5-HT(2A) and 5-HT(1A) receptors in the regulation of catalepsy was suggested. This suggestion was confirmed by prevention of DOI anticataleptic effect in ASC/Icg and CBA/Lac mice by pretreatment with 5-HT(1A) receptor antagonist p-MPPI (3 mg/kg, i.p.). At the same time, the activation of 5-HT(2A) receptor led to the essential suppression of 5-HT(1A) receptor functional activity, indicating the opposite effect of 5-HT(2A) receptor on pre- and postsynaptic 5-HT(1A) receptors. Thus, 5-HT(2A)/5-HT(1A) receptor interaction in the mechanism of catalepsy suppression in mice was shown.
在本研究中,我们研究了 5-羟色胺(2A)和 5-羟色胺(1A)受体的功能活性以及脑内 5-羟色胺(2A)受体基因表达,研究对象为易发生僵住症的 ASC/Icg 和同基因 AKR.CBAD13Mit76C 小鼠品系(遗传易患僵住症),并与僵住症抗性 AKR/J 和易患僵住症 CBA/Lac 小鼠进行了比较。结果发现,与僵住症抗性 AKR/J 相比,所有易发生僵住症的小鼠的额皮质中 5-羟色胺(2A)受体功能活性明显降低,5-羟色胺(2A)受体基因表达减少。5-羟色胺(2A)激动剂 DOI(0.5 和 1 mg/kg,腹腔注射)可显著降低 ASC/Icg 和 CBA/Lac 小鼠的僵住症,但对 AKR.CBAD13Mit76C 小鼠无效。与僵住症抗性 AKR/J 相比,易发生僵住症的小鼠品系中 5-羟色胺(1A)受体的功能活性显著增加。然而,在 AKR.CBAD13Mit76C 小鼠中,其活性低于 ASC/Icg 和 CBA/Lac 小鼠。这表明 5-羟色胺(2A)和 5-羟色胺(1A)受体在调节僵住症方面存在相互关系。这一推测得到了证实,即预先给予 5-羟色胺(1A)受体拮抗剂 p-MPPI(3 mg/kg,腹腔注射)可预防 DOI 对 ASC/Icg 和 CBA/Lac 小鼠的抗僵住作用。同时,5-羟色胺(2A)受体的激活导致 5-羟色胺(1A)受体功能活性的显著抑制,表明 5-羟色胺(2A)受体对突触前和突触后 5-羟色胺(1A)受体的作用相反。因此,我们在小鼠中显示了 5-羟色胺(2A)/5-羟色胺(1A)受体相互作用在抑制僵住症机制中的作用。